HOMA-IR is a calculated score that combines fasting glucose and fasting insulin to estimate insulin resistance. The formula (glucose × insulin ÷ 405 in US units) produces a single number reflecting how hard your body must work to maintain glucose balance.
HOMA-IR is the most practical insulin resistance marker available from routine bloodwork, making it a cornerstone of metabolic assessment. The longevity consensus targets under 1.0, with values between 1.0-2.0 indicating early metabolic stress and anything above 2.0 reflecting meaningful insulin resistance. It's more informative than either fasting glucose or fasting insulin alone because it captures the interaction. A person can have normal glucose with elevated insulin and still score poorly.
Optimal HOMA-IR: 0.5-1.5 index.
Typically re-tested every 10 weeks.
HOMA-IR, short for Homeostatic Model Assessment of Insulin Resistance, is a number calculated from a single fasting blood draw that estimates how much insulin your body needs to hold blood sugar in range.
It is not a direct measurement. It is a model. The calculation multiplies fasting insulin by fasting glucose and divides by a constant, which produces a single index value with no units attached. When glucose is reported in mg/dL, the formula is fasting insulin (µIU/mL) multiplied by fasting glucose (mg/dL), divided by 405. When glucose is reported in mmol/L, the divisor is 22.5 instead. The two versions give the same answer, they just match different lab conventions.
The logic behind the model is the feedback loop between your liver and the beta cells of your pancreas. Insulin tells the liver to stop releasing stored glucose and tells muscle and fat cells to take glucose in. When those tissues respond less readily, the pancreas compensates by releasing more insulin. For a while, that compensation works, and fasting glucose stays normal while fasting insulin climbs quietly. HOMA-IR captures that trade-off in one number, because it rises when either value rises, and rises sharply when both do.
That is the practical value of the index. A normal glucose on its own tells you the system is still holding. HOMA-IR tells you something about the effort behind it.
Related: HOMA-IR Test Cost, What Actually Drives the Price
It matters because insulin resistance is upstream of several of the biggest drivers of long-term health risk, and it tends to be measurable earlier than the conditions it precedes.
Insulin does far more than move sugar. It influences how fat is stored and released, how the liver packages triglycerides, how the kidneys handle sodium and uric acid, and how blood vessel linings behave. When tissues stop responding well to it, the downstream effects show up across systems rather than in one place. That is why insulin resistance is associated with patterns that include higher triglycerides, lower HDL, higher blood pressure, more fat stored in and around the liver, and shifts in reproductive hormones.
The timeline is the other reason to pay attention. Fasting glucose and HbA1c are useful markers, but both can stay inside standard ranges while compensation is still succeeding. Tracking the insulin side of the equation gives you a longer runway, which is the whole point of measuring something before symptoms exist.
Insulin sensitivity also connects to areas people do not always associate with metabolism. A large meta-analysis of metabolic parameters found that insulin resistance and related metabolic measures differ meaningfully in people with depression compared with controls, which suggests metabolic health and mood are linked in both directions[1]. This is an association, not a cause, and it does not mean a HOMA-IR result says anything about your mental health.
None of this makes a single HOMA-IR value a verdict. It is one estimate, from one morning, of one part of a larger system. Its value comes from being tracked over time and read alongside other markers.
Most laboratories treat a HOMA-IR index between roughly 0.5 and 2.5 as the typical reference range for adults, with values above that range flagged for review.
| Marker | Typical lab reference range | FitScript optimal range |
|---|---|---|
| HOMA-IR (index) | 0.5 to 2.5 | 0.5 to 1.5 |
In 21,684 healthy adults aged 20 to 60, HOMA-IR ranges were almost the same for men and women, and the authors found no reason to split them.[13]
| Sex | Age | Reference range (index) |
|---|---|---|
| Men | 20 to 60 | 0.38 to 2.81 |
| Women | 20 to 60 | 0.39 to 2.86 |
| Men and women | 20 to 60 | 0.39 to 2.86 |
HOMA-IR is calculated from fasting glucose and fasting insulin, and insulin assays differ between labs, so results from different labs are not always comparable.
Reference ranges vary by laboratory, by the insulin assay used, and by age and sex, so always read your result against the range printed on your own report. FitScript's optimal range is an optimization target, not a diagnostic cut-off, and sitting outside it does not mean a condition is present.
The gap between the two ranges is worth understanding. A standard reference range is built to separate people who likely need clinical attention from people who likely do not. An optimal range is narrower on purpose, because the goal is different. It asks where a marker tends to sit in people whose metabolic systems are working with the least strain, not where the threshold for concern begins.
One technical caveat matters more here than with most markers. Insulin assays are not fully standardized between laboratories, so the same blood sample can produce somewhat different insulin values, and therefore different HOMA-IR results, at different labs. Trend lines measured the same way at the same lab are more informative than a single number compared across providers.
A HOMA-IR above the standard range suggests your body is producing more insulin than usual to keep fasting glucose where it is, which is the working definition of reduced insulin sensitivity.
What people notice. Many people with a raised result feel nothing at all, which is exactly why it gets measured. Others describe a cluster of non-specific experiences, including energy dips a couple of hours after meals, stronger carbohydrate cravings, difficulty losing weight around the midsection, increased hunger shortly after eating, and skin changes such as darkened velvety patches at the neck or armpits. None of these confirms anything on its own, and all of them have other explanations.
Common contributors. Excess visceral fat, low muscle mass, physical inactivity, short or fragmented sleep, chronic psychological stress, and dietary patterns heavy in refined carbohydrate and ultra-processed food all push in the same direction. Genetics and family history contribute. So do several clinical situations, including polycystic ovary syndrome, where insulin resistance is a central feature and where dietary patterns have been compared directly for their effect on metabolic and reproductive outcomes[2]. Pregnancy, acute illness, and some prescribed medications also raise insulin independently of lifestyle.
What it can mean over time. Sustained insulin resistance is associated with a higher likelihood of progressing toward prediabetes and type 2 diabetes, with fat accumulation in the liver, with an atherogenic lipid pattern, and with higher cardiovascular risk. The word to use for a raised result is suboptimal, not dangerous. It describes a trajectory, not a diagnosis.
A sensible next step. Bring the result, the underlying fasting insulin and glucose values, and your lipid panel to a clinician together. A markedly raised index, or one accompanied by a fasting glucose above the standard range, is worth discussing with a clinician promptly rather than waiting for the next annual check. Never treat an out-of-range result as something to ignore.
A low HOMA-IR usually means the straightforward thing, that your tissues respond efficiently to insulin and your pancreas does not need to work hard to maintain fasting glucose.
What people notice. Typically nothing, because good insulin sensitivity is unremarkable to live with. Some people with very low fasting insulin report shakiness, irritability or lightheadedness when meals are delayed, though those experiences are common and are not specific to this marker.
Common contributors. Lean body composition, substantial muscle mass, regular physical activity, consistent sleep, and lower-carbohydrate or lower-calorie eating patterns all tend to lower both fasting insulin and the index. An extended fast before the draw does the same thing temporarily. Some medications that a licensed provider prescribes also lower fasting insulin, which is an expected effect rather than a finding.
When a low number deserves a closer look. The index assumes the pancreas is capable of responding. If fasting insulin is low while fasting glucose sits above the standard range, the model can produce a reassuring-looking number while describing a very different situation, one where insulin output may be limited rather than unnecessary. That combination is worth discussing with a clinician promptly. The index is also not a valid measure of insulin resistance in anyone using injected insulin, because the measured insulin is not coming from their own pancreas.
Testing conditions, recent behaviour, medications and longer-term habits all move this number, and the first three can move it enough to change how a single result reads.
Testing conditions. The calculation assumes a true fasting state, generally eight to twelve hours without food or caloric drinks. Eating beforehand, a very long fast, an acute illness or infection, significant recent stress, a poor night of sleep, or an unusually hard training session in the preceding day or two can all shift fasting insulin or glucose. Time of day matters, since both values follow a daily rhythm, so repeat tests are best drawn in the morning under similar conditions. Sample handling and assay differences between laboratories add further variation.
Medications and medical context. Some prescribed medicines, including some hormonal preparations, are known to affect glucose and insulin. Medications used for metabolic conditions generally move the index in the opposite direction. A licensed provider evaluates whether any prescription treatment is appropriate for an individual, and decides on it after reviewing the whole picture. Pregnancy changes insulin sensitivity substantially by design.
Movement. Exercise is one of the most consistently studied influences on insulin sensitivity. A systematic review and meta-analysis in people with type 2 diabetes found that structured exercise improved measures of insulin resistance, with both aerobic and resistance training contributing[3]. Muscle is the largest site of glucose disposal in the body, so building and using it tends to matter.
Dietary pattern. Higher intakes of dietary fibre and whole grains have been associated with improved glycemic outcomes in people managing diabetes across pooled analyses[4]. Mediterranean-style eating patterns have been evaluated in controlled trials in adults and are associated with improvements across several metabolic health measures[5]. Meal timing has been studied too, with randomized trials pooled to examine how breakfast skipping relates to body composition and cardiometabolic risk markers[6]. One proposed mechanism linking fibre intake to metabolic outcomes runs through gut fermentation, and short-chain fatty acids have been examined for their relationship with insulin sensitivity in a systematic review and meta-analysis[7].
Supplements. Several have been studied in people with type 2 diabetes, with modest and inconsistent findings. Chromium supplementation has been pooled across randomized controlled trials for its effect on glycemic control[8], as has cinnamon in an updated dose-response review[9]. Curcumin has been assessed across a large body of randomized trials spanning many health outcomes[10]. Small effects for some people are possible but not established, and none of these is a substitute for the structural changes above. Discuss any supplement with a clinician, particularly alongside prescribed medication.
Combinations, and watching the rest of your bloodwork. Diet and physical activity are usually studied and applied together, and combined interventions have been evaluated in pooled analyses across clinical populations[11]. It is also worth remembering that changing how you eat changes markers beyond glucose and insulin. Analyses of iron status have found meaningful differences between vegetarian and omnivorous eating patterns[12], which is a good argument for retesting broadly rather than narrowly after a significant dietary shift.
FitScript measures the two inputs, fasting insulin and fasting glucose, on the same fasted morning draw and reports the calculated index alongside them, so the number and its components are always read together.
The relevant panel is Metabolic + Insulin, which groups the glucose and insulin markers with the lipid and metabolic measures that give the index context. Because the membership includes 150+ biomarkers tested per year, the index is not read as an isolated data point. It sits next to lipids, liver markers, inflammatory markers and body composition, which is where its meaning actually lives.
Atlas, the AI health advisor, interprets each result in that wider context and writes it into your FitScript, the personalized output generated from your own biology. Where a result suggests a treatment might be worth considering, a licensed provider reviews the member and evaluates whether any prescription option is appropriate. No treatment decision is made from a number alone, and no dosing guidance comes from software.
The most useful thing about tracking this marker through repeat testing is the slope. Two results, measured under similar fasting conditions at the same lab a few months apart, say far more than one result ever can.
The index is only as informative as the markers around it, and six in particular change how it reads.
Fasting Insulin is one of the two inputs and often the one that moves first, so seeing it directly tells you which side of the calculation is driving a change. Fasting Glucose is the other input and the marker that stays normal longest during compensation. Hemoglobin A1C reflects average glucose exposure over roughly the preceding three months, which smooths out the single-morning variability that affects any fasting draw.
On the lipid side, the Triglyceride/HDL Ratio is widely used as a practical proxy for insulin sensitivity and tends to track with the index, while Triglycerides alone respond quickly to carbohydrate intake and liver fat. Uric Acid is worth including because insulin influences how the kidneys clear it, and raised levels often travel with the same metabolic pattern.
Read as a group, these markers either corroborate the index or complicate it, and both outcomes are useful.
HOMA-IR is an early, inexpensive estimate of how hard your body is working to manage blood sugar, drawn from two fasting values you may already have on file. It is most useful when it is repeated under consistent conditions and interpreted alongside lipids, HbA1c and body composition rather than on its own. A result outside the standard range is a prompt to look closer, not a conclusion, and a result inside it is not a guarantee that nothing is changing.
This article is educational information and not medical advice. Discuss your results and any treatment decisions with a clinician or licensed provider who can review your full history.
Calculators that use HOMA-IR:
It multiplies fasting insulin by fasting glucose and divides by a constant. With glucose in mg/dL, the divisor is 405 and insulin is in µIU/mL. With glucose in mmol/L, the divisor is 22.5. Both versions produce the same unitless index, they just match different lab reporting conventions.
Most laboratories treat roughly 0.5 to 2.5 as the typical adult reference range, though this varies by lab, assay, age and sex. FitScript's optimal range is 0.5 to 1.5, which is an optimization target rather than a diagnostic cut-off. Always compare your value against the range printed on your own report.
Yes. The calculation assumes a true fasting state, generally eight to twelve hours without food or caloric drinks, because both inputs are fasting values. Eating beforehand, an unusually long fast, acute illness or a very hard recent workout can all shift the result enough to change how it reads.
It can, and that combination deserves attention rather than reassurance. The model assumes the pancreas is able to respond. If fasting insulin is low while glucose sits above the standard range, the index can look fine while describing limited insulin output. That pattern is worth discussing with a clinician promptly.
They answer different questions. HbA1c reflects average glucose exposure over roughly the previous three months and can stay in range while insulin is already climbing. The index captures the insulin side, so it often shifts earlier. Neither replaces the other, and both are best read together with lipids.
That depends on your starting point and what you are changing, so a clinician should set the interval. In general, retesting a few months apart under the same fasting conditions and at the same laboratory gives a usable trend. Insulin assays differ between labs, so comparing across providers is less reliable.
Structured exercise comes first, and both aerobic and resistance training may improve insulin sensitivity. Higher fibre and whole grain intake and Mediterranean-style eating patterns are also associated with better metabolic measures. Sleep and stress matter too. Supplement findings are smaller and less consistent.
It is not a valid measure of your own insulin resistance if you use injected insulin, because the measured insulin is not produced by your pancreas. Other glucose-lowering medications also shift the result. Tell the ordering clinician what you take so the value is interpreted correctly.
No. A single index value cannot establish any diagnosis. A raised result is a suboptimal signal that insulin output may be elevated, and it is read alongside fasting glucose, HbA1c, lipids and your history. Only a clinician reviewing the full picture can determine what, if anything, it indicates.